Business Description
AP Biosciences Inc
ISIN : TW0006945009
Total Employee Number:
37Description
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 19.68 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 2.6 | |||||
3-Year EPS without NRI Growth Rate | 1.5 | |||||
3-Year FCF Growth Rate | 5.7 | |||||
3-Year Book Growth Rate | -4.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 13.68 | |||||
9-Day RSI | 24.87 | |||||
14-Day RSI | 30.51 | |||||
3-1 Month Momentum % | -40.06 | |||||
6-1 Month Momentum % | -41.11 | |||||
12-1 Month Momentum % | 23.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 29.94 | |||||
Quick Ratio | 29.94 | |||||
Cash Ratio | 28.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9.7 | |||||
Shareholder Yield % | -0.05 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -17.36 | |||||
ROA % | -16.18 | |||||
ROIC % | -158.01 | |||||
3-Year ROIIC % | -109.11 | |||||
ROC (Joel Greenblatt) % | -204.09 | |||||
ROCE % | -16.63 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 5.87 | |||||
Price-to-Tangible-Book | 5.88 | |||||
EV-to-EBIT | -30 | |||||
EV-to-EBITDA | -31.76 | |||||
EV-to-FCF | -21.81 | |||||
| Price-to-Net-Current-Asset-Value | 6.62 | |||||
| Price-to-Net-Cash | 6.93 | |||||
Earnings Yield (Greenblatt) % | -3.33 | |||||
FCF Yield % | -4.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AP Biosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | |||
| EPS (TTM) (NT$) | -2.91 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 77.33 | ||
| 14-Day RSI | 30.51 | ||
| 14-Day ATR (NT$) | 5.178699 | ||
| 20-Day SMA (NT$) | 101.34 | ||
| 12-1 Month Momentum % | 23.02 | ||
| 52-Week Range (NT$) | 79.1 - 236 | ||
| Shares Outstanding (Mil) | 97.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AP Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AP Biosciences Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
AP Biosciences Inc Frequently Asked Questions
What is AP Biosciences Inc(ROCO:6945)'s stock price today?
The current price of ROCO:6945 is NT$87.20. The 52 week high of ROCO:6945 is NT$236.00 and 52 week low is NT$79.10.
When is next earnings date of AP Biosciences Inc(ROCO:6945)?
The next earnings date of AP Biosciences Inc(ROCO:6945) is .
Does AP Biosciences Inc(ROCO:6945) pay dividends? If so, how much?
AP Biosciences Inc(ROCO:6945) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on AP Biosciences Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers